Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-41,285
Closed -$2.76M 1102
2014
Q1
$2.76M Sell
41,285
-3,986
-9% -$269K ﹤0.01% 835
2013
Q4
$3.02M Sell
45,271
-3,161
-7% -$205K ﹤0.01% 834
2013
Q3
$3.04M Sell
48,432
-3,288
-6% -$212K ﹤0.01% 817
2013
Q2
$3.23M Buy
+51,720
New +$3.28M ﹤0.01% 769

Other funds holding GSK

Janus Henderson Investors US's GSK Position: Q2 2014 in Review

Janus Henderson Investors US sold out of GSK (GSK) in Q2 2014, closing a stake of 41,285 shares — an estimated $2.76M sold.

Janus Henderson Investors US first reported a position in GSK in Q2 2013 and held it in 4 quarters. The position peaked at $3.23M in Q2 2013. 722 funds tracked by Wall St. Rank hold GSK as of Q2 2014.

  • Janus Henderson Investors US reported no remaining GSK position as of Q2 2014 after selling out during the quarter.
  • Janus Henderson Investors US sold 41,285 GSK shares in Q2 2014, an estimated $2.76M.
  • Janus Henderson Investors US first reported a position in GSK in Q2 2013 and held it in 4 quarters.
  • Janus Henderson Investors US's GSK position peaked at $3.23M in Q2 2013.
  • 722 funds tracked by Wall St. Rank held GSK as of Q2 2014.

Based on Janus Henderson Investors US's 13F filing for Q2 2014, filed 14 Aug 2014.